Approval of a cheap version of HIV-prevention shot lenacapavir raises hopes in low-income countries
The U.S. Food and Drug Administration has approved a generic version of lenacapavir, an HIV-prevention shot that people take twice a year. This approval is significant because it should make the drug available at lower cost and faster to reach around 120 low- and middle-income countries, where access to HIV prevention has been limited.
11 across the spectrum. Choose a side on the bar to jump to it.
National story. 12 articles from 11 sources. Updated 1d ago.
Left
1 sourceSame wire story as other sides. No original Left take here.
Approval of a cheap version of HIV-prevention shot lenacapavir raises hopes in low-income countries
Center
8 sourcesSTAT+: FDA OKs generic HIV prevention shot, widening access for lower-income countries
Right
2 sourcesApproval of a cheap version of HIV-prevention shot lenacapavir raises hopes in low-income countries